THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE
Clinical trials for THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE trials appear
Sign up with your email to follow new studies for THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to protect unborn babies from Life-Threatening bleeding
Disease control Recruiting nowThis study is testing whether an investigational drug called nipocalimab works better than the current standard treatment (IVIG) to prevent severe bleeding and low platelet counts in babies at risk of a rare immune condition called FNAIT. It will enroll about 50 pregnant women wh…
Matched conditions: THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug trial aims to stop deadly bleeding in unborn babies
Prevention Recruiting nowThis study is testing whether an investigational drug called nipocalimab can prevent a serious bleeding condition in newborns. It is for pregnant women who have had a previous baby affected by this immune disorder. The goal is to see if giving the drug to the mother during pregna…
Matched conditions: THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC